tiprankstipranks
Trending News
More News >
Galera Therapeutics, Inc. (GRTX)
:GRTX
US Market
Advertisement

Galera Therapeutics (GRTX) Income Statement

Compare
261 Followers

Galera Therapeutics Income Statement

Last quarter (Q1 2025), Galera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Galera Therapeutics's net income was $-1.59M. See Galera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.84M$ -259.00K$ -114.00K$ -778.00K$ -368.00K
Operating Expenses
$ 14.15M$ 46.69M$ 51.23M$ 73.37M$ 70.55M
Depreciation and Amortization
$ 0.00$ 259.00K$ 114.00K$ 778.00K$ 368.00K
EBITDA
$ -20.16M$ -46.69M$ -50.61M$ -72.56M$ -69.01M
Operating Income
$ -20.16M$ -46.95M$ -51.23M$ -73.37M$ -70.55M
Other Income/Expenses
$ 1.00M$ -12.13M$ -11.07M$ -7.17M$ -3.68M
Pretax Income
$ -19.16M$ -59.08M$ -62.29M$ -80.53M$ -74.23M
Net Income
$ -18.96M$ -59.08M$ -62.22M$ -80.53M$ -74.22M
Per Share Metrics
Basic EPS
$ -0.35$ -1.33$ -2.30$ -3.40$ -2.98
Diluted EPS
$ -0.35$ -1.33$ -2.30$ -3.40$ -2.98
Weighted Average Shares Outstanding
54.63M 44.55M 27.09M 25.79M 24.87M
Weighted Average Shares Outstanding (Diluted)
54.63M 44.55M 27.09M 25.79M 24.87M
Currency in USD

Galera Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis